Wellcrop Biotech Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 30-12-2024
- Paid Up Capital ₹ 8.00 M
as on 30-12-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.40 Cr
as on 30-12-2024
- Satisfied Charges ₹ 3.21 Cr
as on 30-12-2024
- Revenue -52.95%
(FY 2020)
- Profit -110.18%
(FY 2020)
- Ebitda 26.44%
(FY 2020)
- Net Worth -0.38%
(FY 2020)
- Total Assets -13.12%
(FY 2020)
About Wellcrop Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹1.40 Cr. The company has closed loans amounting to ₹3.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nileshbhai Vadsola and Shantilal Kundariya serve as directors at the Company.
- CIN/LLPIN
U24120GJ2014PTC080180
- Company No.
080180
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2014
- Date of AGM
19 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Wellcrop Biotech Private Limited offer?
Wellcrop Biotech Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Organic Fertilizers and Manure, Bio Fertilizers.
Who are the key members and board of directors at Wellcrop Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nileshbhai Vadsola  | Director | 21-Jul-2014 | Current |
| Shantilal Kundariya | Director | 01-Feb-2021 | Current |
Financial Performance of Wellcrop Biotech.
Wellcrop Biotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 52.95% decrease. The company also saw a substantial fall in profitability, with a 110.18% decrease in profit. The company's net worth dipped by a decrease of 0.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wellcrop Biotech?
In 2019, Wellcrop Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Feb 2021 | ₹1.40 Cr | Open |
Indian Overseas Bank Creation Date: 07 May 2015 | ₹1.61 Cr | Satisfied |
Indian Overseas Bank Creation Date: 04 May 2015 | ₹1.61 Cr | Satisfied |
How Many Employees Work at Wellcrop Biotech?
Unlock and access historical data on people associated with Wellcrop Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellcrop Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellcrop Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
